Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 5.00
0.00 (0.00%)
Jul 3, 2026, 4:28 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 11.74 million as of July 2, 2026. Its market cap has decreased by -91.88% in one year.
Market Cap
11.74M
Enterprise Value
-3.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.00
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 11.74M, a decrease of -94.06%. That is a compound annual growth rate of -42.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 11.74M | -87.35% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 83.17M |
| Alzinova AB | 76.71M |
| 2cureX AB | 67.63M |
| Pila Pharma AB | 57.10M |
| Fluicell AB | 45.47M |
| Modus Therapeutics Holding AB | 45.00M |
| Guard Therapeutics International AB | 31.06M |
| Magle Chemoswed Holding AB | 29.32M |